{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:33:59Z","timestamp":1757705639178},"reference-count":13,"publisher":"Royal College of Psychiatrists","issue":"1","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":10593,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1989,1]]},"abstract":"<jats:p>Two cases are presented in which psychotic patients with neuroleptic malignant syndrome were treated with bromocriptine and thioridazine simultaneously, with a resulting control of both problems. The authors feel that this method needs further study, in the light of the potentially large number of patients at risk for these illnesses. The use of creatinine phosphokinase level as an indicator of value in NMS is also discussed.<\/jats:p>","DOI":"10.1192\/bjp.154.1.102","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T20:01:46Z","timestamp":1218571306000},"page":"102-104","source":"Crossref","is-referenced-by-count":21,"title":["Concomitant Treatment of Neuroleptic Malignant Syndrome and Psychosis"],"prefix":"10.1192","volume":"154","author":[{"given":"Harry D.","family":"Goldwasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicki M.","family":"Spears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000225221_ref13","first-page":"69","article-title":"Bromocriptine treatment of neuroleptic malignant syndrome","volume":"48","author":"Suhayl","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000225221_ref12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM198511143132015","article-title":"Neuroleptic malignant syndrome (letter)","volume":"313","author":"Shalev","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"S0007125000225221_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(85)72810-1"},{"key":"S0007125000225221_ref7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5694\/j.1326-5377.1986.tb113872.x","article-title":"Neuroleptic malignant syndrome","volume":"145","author":"Ingall","year":"1986","journal-title":"Medical Journal of Australia"},{"key":"S0007125000225221_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1987.tb02944.x"},{"key":"S0007125000225221_ref2","first-page":"102","article-title":"ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome","volume":"48","author":"Addonizio","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000225221_ref5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM198511143132015","article-title":"Neuroleptic malignant syndrome (letter)","volume":"313","author":"Fogel","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"S0007125000225221_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(85)72761-2"},{"key":"S0007125000225221_ref4","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000225221_ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198406000-00001"},{"key":"S0007125000225221_ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507183130306"},{"key":"S0007125000225221_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/106002808401800704"},{"key":"S0007125000225221_ref1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1176\/ajp.143.12.1587","article-title":"Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients","volume":"143","author":"Addonizio","year":"1986","journal-title":"American Journal of Psychiatry"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000225221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:39:13Z","timestamp":1588855153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000225221\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["S0007125000225221"],"URL":"https:\/\/doi.org\/10.1192\/bjp.154.1.102","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}